go back

Brexucabtagene Autoleucel (Tecartus) CAR-T Therapy

South Carolina rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $537,032 · 10th–90th $489,779$1,096,4780%20%10th90th$537,032Professionalmedian $489,779 · 10th–90th $489,779$537,0320%50%90th$489,779$50.0$500.0$5.0K$50.0K$500.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$512,861.38
Median
$691,830.97
Typical High
$2,089,296.13
Aetna
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$537,031.80
BCBS
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$549,540.87
Typical High
$630,957.34
Cigna
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$588,843.66
Medcost
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$537,031.80
Typical High
$870,963.59
Molina
Setting
Professional
Modifier
Global
Typical Low
$30.20
Median
$30.20
Typical High
$1,230,268.77
United
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$812,830.52
United
Setting
Professional
Modifier
Global
Typical Low
$363,078.05
Median
$489,778.82
Typical High
$660,693.45